News
Waga Energy announces the launch of an accelerated bookbuild offering for a minimum amount of €45 million
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today presented the discovery of SGR-1505, its MALT1
EQS-News: AUSTRIACARD HOLDINGS AG: RESIGNATION OF GROUP-CEO
Kyndryl and Cloudflare Announce Global Strategic Alliance to Drive Enterprise Network Transformation, Multi-Cloud Innovation, and Zero Trust Security
Kyndryl (NYSE: KD), the world’s largest IT infrastructure services provider, and Cloudflare, Inc. (NYSE: NET), a leading connectivity cloud company, today announced a Global Strategic Alliance, an
EQS-News: The Platform Group closes acquisition of stake in Mister Spex SE
Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc
Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant
Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), today announced TVGN 489, its investigational allogeneic SARS-CoV-2 specific Cytotoxic CD8+ T lymphocytes (CTLs) immunotherapy for treatment of
Ault Alliance Issues Letter to Stockholders
Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today shared a letter from its Executive Chairman to its stockholders.
Dear
EQS-Adhoc: Altech Advanced Materials AG: publishes results of final feasibility study for CERENERGY battery plant
Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Compensation Committee of its Board of Directors granted, on November 15, 2023 and
EQS-Adhoc: Brockhaus Technologies AG: Executive Board to propose first-time dividend of EUR 0.22 per share; steadily increasing dividend targeted for the future
MaaT Pharma To Present New Preclinical Data at AACR for MaaT034 Aiming To improve Patients’ Responses to Immunotherapies
Regulatory News:
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to
The Cannabist Company Announces Closing of US$25.75 Million Private Placement Offering of 9% Senior Secured Convertible Debentures Due 2027
The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”) announced today that it has completed a private placement of US$19.5 million
Ault Alliance Announces New Telemedicine Initiative at GuyCare
Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today announced that GuyCare, Inc. (“GuyCare”), a subsidiary of RiskOn International
UiPath Unveils New Family of LLMs at AI Summit to Empower Enterprises to Harness Full Capabilities of GenAI
UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced several new generative AI (GenAI) features in its platform designed to help enterprises realize the
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on March 15, 2024, the company
EQS-News: Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
Elliptic Labs Chosen for Transsion’s Infinix Note 40 Series Smartphones
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensors™ currently deployed in over 500 million devices, has launched its AI Virtual Proximity
EQS-News: Instone Group achieves upper end of earnings guidance; outlook for 2024 assumes continued solid profitability in a year of transition
GE HealthCare Accelerates AI Innovation with Healthcare-Specific Foundation Models Powered by NVIDIA
Building on a long-term artificial intelligence (AI) collaboration, GE HealthCare used NVIDIA technology to develop its recent research model SonoSAMTrack1, which combines a promptable foundation
Ault Alliance Declares Monthly Cash Dividend of $0.2708333 Per Share of 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock
Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), today announced that its Board of Directors has declared a monthly cash dividend of